Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|14|13|1574-1589

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.13, 2014-07, pp. : 1574-1589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

By Tamamura Hirokazu   Fujii Nobutaka  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1267-1282

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR4 chemokine receptor antagonists: perspectives in SCLC

By Burger Jan A   Stewart David J  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 481-490

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1427-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Low Molecular Weight CXCR4 Antagonists by Exploratory Structural Tuning of Cyclic Tetra- and Pentapeptide-Scaffolds Towards the Treatment of HIV Infection, Cancer Metastasis and Rheumatoid Arthritis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 93-102

Bentham Science Publishers

Access to resources Recommend Favorite